SAFETY AND IMMUNOGENICITY OF A REPLICATION DEFICIENT SIMIAN ADENOVIRAL VECTORED CHIKUNGUNYA VACCINE: A PHASE I, FIRST-IN-HUMAN, DOSE ESCALATION TRIAL
2019
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI